Alan K L. Kai, et.al., Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013, 27

http://rdf.ncbi.nlm.nih.gov/pubmed/23825225

Alan K L. Kai, et.al., Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013, 27

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Rapgef3<tm1Skc>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5532318

class

http://purl.org/net/cito/citesAsAuthority

• Rapgef3<tm1Skc>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5532318

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating HDL cholesterol level_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0000186NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• increased body weight_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0001260NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• increased circulating triglyceride level_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0001552NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• hyperglycemia_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0001559NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• decreased circulating insulin level_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0002727NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• decreased insulin secretion_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0003059NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
他11件を見る
• abnormal pancreatic beta cell physiology_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0003562NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• insulitis_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0004031NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• decreased circulating cholesterol level_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0005179NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• impaired glucose tolerance_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0005293NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• insulin resistance_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0005331NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• pancreatic islet hyperplasia_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0005491NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• decreased blood urea nitrogen level_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0005566NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• increased susceptibility to diet-induced obesity_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0005658NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• enlarged pancreatic islets_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0009171NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• increased pancreatic alpha cell number_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0009176NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc
• increased respiratory quotient_Rapgef3<tm1Skc>/Rapgef3<tm1Skc>
  http://metadb.riken.jp/0010378NSRapgef3tm1SkcRapgef3tm1SkcRapgef3tm1Skc